ArticleClinical neuropsychiatry2025
Jumping to Conclusions and Facial Emotion Recognition in First-Episode Psychosis: Longitudinal Insights from the Gap Follow-Up Study.
Article in Clinical neuropsychiatry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
21 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: Psychotic disorders are heterogeneous in their clinical presentation and outcome. While early research focused on poor prognoses in schizophrenia, recent longitudinal studies tracking first-episode psychosis (FEP) have identified more favourable outcome trajectories. This study investigates the stability and predictive value of metacognitive and social cognitive impairments-Jumping to Conclusions (JTC) bias and Facial Emotion Recognition (FER) deficits-as intermediate phenotypes of psychosis over a 5-year follow-up period. Method: A total of 134 FEP patients and 105 population-based controls from the GAP and EU-GEI follow-up study in London were reassessed after an average of 4.8 years. JTC was measured using the 60:40 Beads task, while FER was assessed through the Degraded Facial Affect Recognition (DFAR) task. Clinical, functional, and social outcomes-including hospital admissions, symptom severity, and employment status-were evaluated. Mixed models and regression modeling examined the stability of these cognitive traits and their association with long-term outcomes. Results: JTC and FER impairments remain stable over time, supporting their classification as intermediate phenotypes. However, neither JTC nor FER was associated with clinical outcomes (hospitalization rates, symptom severity) or social functioning (employment, independent living, relationships). A weak correlation was found between global FER impairment and negative symptoms at follow-up, but no associations emerged with real-world functional measures. Additionally, while patients demonstrated greater impairments than controls, the differences were more quantitative than qualitative, aligning with the psychosis continuum hypothesis. Conclusions: These findings demonstrate that JTC and FER are stable in people with psychosis and controls. Therefore, they may serve as important treatment targets for early intervention in psychosis. Future research should integrate the potential role of environmental factors as well as genetic influence to deepen our understanding of cognitive impairments in psychotic disorders.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.